Keith P Klugman
Overview
Explore the profile of Keith P Klugman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
318
Citations
11156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ginsburg A, Duncan K, Klugman K, Srikantiah P
Lancet Glob Health
. 2024 Nov;
12(12):e1928-e1929.
PMID: 39541991
No abstract available.
2.
von Gottberg A, Kleynhans J, de Gouveia L, Tempia S, Meiring S, Quan V, et al.
Lancet Glob Health
. 2024 Aug;
12(9):e1470-e1484.
PMID: 39151982
Background: In South Africa, 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and 13-valent PCV (PCV13) was introduced in 2011, both in a two plus one schedule. We evaluated...
3.
Howard L, Huang X, Chen W, Liu Y, Edwards K, Griffin M, et al.
Int J Infect Dis
. 2023 Jul;
134:248-255.
PMID: 37451394
Objectives: We examined the association of nasopharyngeal (NP) pneumococcal co-colonization (>1 pneumococcal serotype) and pneumococcal density in young Peruvian children enrolled in a prospective cohort study. Methods: NP swabs collected...
4.
Srikantiah P, Klugman K
BMC Med
. 2023 May;
21(1):177.
PMID: 37183242
As new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease burden and the full potential and cost effectiveness of...
5.
Ginsburg A, Srikantiah P, Dowell S, Klugman K
Lancet Glob Health
. 2022 Nov;
10(12):e1709-e1710.
PMID: 36372077
No abstract available.
6.
7.
Egorova E, Kumar N, Gladstone R, Urban Y, Voropaeva E, Chaplin A, et al.
Microb Genom
. 2022 Sep;
8(9).
PMID: 36112007
Invasive pneumococcal disease remains one of the leading causes of morbidity and mortality worldwide. In Russia, 13- valent pneumococcal conjugate vaccine (PCV13) was introduced into the childhood immunization programme nationwide...
8.
Lo S, Mellor K, Cohen R, Alonso A, Belman S, Kumar N, et al.
Lancet Microbe
. 2022 Aug;
3(10):e735-e743.
PMID: 35985351
Background: Serotype 24F is one of the emerging pneumococcal serotypes after the introduction of pneumococcal conjugate vaccine (PCV). We aimed to identify lineages driving the increase of serotype 24F in...
9.
Mazur N, Terstappen J, Baral R, Bardaji A, Beutels P, Buchholz U, et al.
Lancet Infect Dis
. 2022 Aug;
23(1):e2-e21.
PMID: 35952703
Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a...
10.
Chaguza C, Ebruke C, Senghore M, Lo S, Tientcheu P, Gladstone R, et al.
Genome Biol Evol
. 2022 Apr;
14(4).
PMID: 35439297
The isolation of Streptococcus pneumoniae serotypes in systemic tissues of patients with invasive disease versus the nasopharynx of healthy individuals with asymptomatic carriage varies widely. Some serotypes are hyper-invasive, particularly...